Parental EMDR Therapy After a Baby's Stay in the NICU
Key facts
- Who runs it
- Kuopio University Hospital
- Where
- Finland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 80 people, planned
- Started
- Mar 2026
- Expected to end
- Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Eye Movement Desensitization and Reprocessing (EMDR)
- treatment as usual (TAU) (Control Group)
- Record updated
- 13 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adults aged 18 years or older
- Presence of post-traumatic stress symptoms
- Eligible to receive EMDR therapy according to clinical assessment
- Ability to understand study procedures and provide informed consent
- Sufficient proficiency in the Finnish language to complete study assessments and participate in therapy
Who cannot take part
- Acute psychiatric condition requiring immediate specialized treatment (e.g., acute psychosis or severe suicidal crisis)
- Severe cognitive impairment or neurological condition that would prevent participation in psychotherapy or completion of study assessments
- Any condition judged by the investigator to interfere with safe participation in the study
- Ongoing trauma-focused psychotherapy at the time of enrollment
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized clinical trial evaluates the effectiveness of eye movement desensitization and reprocessing (EMDR) therapy in reducing symptoms of post-traumatic stress disorder (PTSD). Participants with PTSD symptoms will be randomly assigned in a 1:1 ratio to either immediate EMDR in addition to treatment as usual (EMDR+TAU) or delayed EMDR following an initial treatment-as-usual period (TAU+EMDR). Randomization will be stratified by sex.
Read full original descriptionShow less
PTSD symptoms will be assessed using the PTSD Checklist for DSM-5 (PCL-5) at baseline (T1), after the first treatment period (T2), and after the second treatment period (T3). The primary outcome is PTSD symptom severity measured by the PCL-5 at T2, comparing participants receiving EMDR+TAU with those receiving TAU alone during the first treatment period.
Secondary outcomes include clinically meaningful improvement in PTSD symptoms, defined as a reduction of at least 10 points on the PCL-5, symptom change during the initial treatment-as-usual period, the effect of delayed EMDR, and the durability of the EMDR treatment effect over time.
The 2 groups in the trial
- EMDR + TAU (Immediate EMDR)Treatment being tested
Participants receive eye movement desensitization and reprocessing (EMDR) therapy in addition to treatment as usual during the first treatment period. PTSD symptoms are assessed at baseline (T1), after the first treatment period (T2), and after the second treatment period (T3).
Treatment: Eye Movement Desensitization and Reprocessing (EMDR) and treatment as usual (TAU) (Control Group)
- TAU + EMDR (Delayed EMDR)Existing treatment, for comparison
Participants receive treatment as usual during the first treatment period. After the first assessment (T2), participants receive EMDR therapy during the second treatment period. PTSD symptoms are assessed at baseline (T1), after the first treatment period (T2), and after the second treatment period (T3).
Treatment: Eye Movement Desensitization and Reprocessing (EMDR) and treatment as usual (TAU) (Control Group)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effectiveness of an EMDR Intervention in Reducing Trauma-Related Symptoms Among Parents Following Their Infant's Birth and Neonatal Intensive Care: A Randomized Controlled Trial
- Record updated
- 13 March 2026